Getting your Trinity Audio player ready... The drugmaker Amgen has sued Colorado’s Prescription Drug Affordability Board for a second time, alleging that the board’s decision last month to set a price ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it. By Rebecca Robbins With a sticker price ...

Enbrel, an injectable medication used to treat conditions like rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis. Photo courtesy Enbrel. Colorado became the first state in the nation ...

Patients with rheumatoid arthritis (RA) who switched from Enbrel (reference etanercept) to a biosimilar maintained remission, even after their dose was reduced, with no signs of worsening based on ...

Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the United States. And unless a court rules otherwise, the Southern California ...

For almost two decades, Medicare was banned from negotiating drug prices. The Inflation Reduction Act changed that. We may earn a commission when you buy through ...

People with rheumatoid arthritis often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body’s immune system and help to limit the ...

Please provide your email address to receive an email when new articles are posted on . In 2026, Stelara will be discounted 66% from its list price for Medicare users, while Enbrel will be discounted ...